#1740 Global Rank Marché Ouvert

Yusuf Hamied

Santé & Biotech. Pharmaceuticals.

Fortune Nette (Est.)

$2.4 B
+$105 (+0.00%) Aujourd'hui
Portefeuille : Cipla Ltd. ▲ High Growth
Yusuf Hamied

Photo: Press Agency / 2026

Profil Financier

Yusuf Hamied occupe actuellement le rang #1740 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.4 B (+$105 sur 24h).

Yusuf Hamied is the non-executive chairman of Mumbai-based generics maker Cipla.

Cipla was founded in 1935 by his father Khwaja Abdul Hamied, a disciple of Mahatma Gandhi.

After the patriarch passed away in 1972, Cambridge-educated Hamied and his brother Mustafa inherited the business.

Hamied took on big pharmaceutical companies, offering low-cost generic drugs for diseases such as AIDS, earning the label of drug pirate.

At the annual shareholders' meeting in 2023, Hamied called reports of a potential stake sale in Cipla by the family to a private equity firm as "speculative."

His niece Samina Hamied was Cipla's executive vice-chairman until March 2024.

Renowned music conductor Zubin Mehta is Hamied's childhood pal.

Cambridge University has named a building after him, making him the first Indian to get that honor.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
Cipla Ltd. (500087-IN) 150.5M parts $2.1 B High Growth